Helius Medical Technologies, Inc. (HSDT)
USD 0.38
(-6.0%)
USD 0.38
(-6.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.69 Million USD | -55.5% |
| 2022 | 17.28 Million USD | 22.59% |
| 2021 | 14.1 Million USD | 115.4% |
| 2020 | 6.54 Million USD | -36.73% |
| 2019 | 10.34 Million USD | -62.82% |
| 2018 | 27.82 Million USD | 308.68% |
| 2017 | 6.8 Million USD | 97.36% |
| 2016 | 3.45 Million USD | 183.64% |
| 2015 | 1.21 Million USD | 13514866.67% |
| 2014 | 9.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 8.84 Million USD | 53.66% |
| 2024 Q1 | 5.75 Million USD | -25.16% |
| 2023 FY | 7.69 Million USD | -55.5% |
| 2023 Q2 | 10.75 Million USD | -21.82% |
| 2023 Q1 | 13.75 Million USD | -20.43% |
| 2023 Q3 | 8.85 Million USD | -17.66% |
| 2023 Q4 | 7.69 Million USD | -13.12% |
| 2022 Q3 | 18.85 Million USD | 188.1% |
| 2022 Q1 | 9.61 Million USD | -31.8% |
| 2022 FY | 17.28 Million USD | 22.59% |
| 2022 Q4 | 17.28 Million USD | -8.34% |
| 2022 Q2 | 6.54 Million USD | -31.94% |
| 2021 Q2 | 10.71 Million USD | -26.92% |
| 2021 Q3 | 7.87 Million USD | -26.48% |
| 2021 Q1 | 14.66 Million USD | 123.98% |
| 2021 FY | 14.1 Million USD | 115.4% |
| 2021 Q4 | 14.1 Million USD | 78.98% |
| 2020 FY | 6.54 Million USD | -36.73% |
| 2020 Q1 | 8.46 Million USD | -18.23% |
| 2020 Q2 | 8.7 Million USD | 2.87% |
| 2020 Q4 | 6.54 Million USD | 8.65% |
| 2020 Q3 | 6.02 Million USD | -30.77% |
| 2019 Q2 | 18.19 Million USD | -19.12% |
| 2019 Q1 | 22.49 Million USD | -19.15% |
| 2019 FY | 10.34 Million USD | -62.82% |
| 2019 Q4 | 10.34 Million USD | -19.67% |
| 2019 Q3 | 12.88 Million USD | -29.22% |
| 2018 Q3 | 13.31 Million USD | -22.09% |
| 2018 Q4 | 27.82 Million USD | 109.05% |
| 2018 FY | 27.82 Million USD | 308.68% |
| 2018 Q2 | 17.08 Million USD | 201.7% |
| 2018 Q1 | 5.66 Million USD | -16.83% |
| 2017 Q4 | 6.8 Million USD | 81.38% |
| 2017 FY | 6.8 Million USD | 97.36% |
| 2017 Q3 | 3.75 Million USD | -56.5% |
| 2017 Q2 | 8.62 Million USD | 0.35% |
| 2017 Q1 | 8.59 Million USD | 149.25% |
| 2016 Q2 | 9.09 Million USD | 125.11% |
| 2016 Q1 | 4.04 Million USD | -23.11% |
| 2016 FY | 3.45 Million USD | 183.64% |
| 2016 Q4 | 3.45 Million USD | -49.28% |
| 2016 Q3 | 6.8 Million USD | -25.22% |
| 2015 Q2 | 1.43 Million USD | 17.59% |
| 2015 Q1 | 1.21 Million USD | -63.87% |
| 2015 Q4 | 5.25 Million USD | 630.84% |
| 2015 FY | 1.21 Million USD | 13514866.67% |
| 2015 Q3 | 719.1 Thousand USD | -49.72% |
| 2014 FY | 9.00 USD | 0.0% |
| 2014 Q3 | 5.39 Million USD | -27.6% |
| 2014 Q4 | 3.36 Million USD | -37.56% |
| 2014 Q1 | 9.00 USD | 0.0% |
| 2014 Q2 | 7.44 Million USD | 82737388.89% |
| 2013 Q2 | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 75.477% |
| BrainsWay Ltd. | 62.97 Million USD | 87.785% |
| Cerus Corporation | 197.74 Million USD | 96.11% |
| Envoy Medical, Inc. | 7.64 Million USD | -0.681% |
| electroCore, Inc. | 16.38 Million USD | 53.06% |
| IceCure Medical Ltd | 16.41 Million USD | 53.126% |
| Inogen, Inc. | 326.19 Million USD | 97.642% |
| OrthoPediatrics Corp. | 449.58 Million USD | 98.289% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 71.793% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 53.604% |
| MaxCyte, Inc. | 268.27 Million USD | 97.133% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | 5.006% |
| Nexalin Technology, Inc. | 3.63 Million USD | -111.789% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.169% |
| PAVmed Inc | 33.11 Million USD | 76.775% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 94.638% |
| RxSight, Inc. | 182.55 Million USD | 95.786% |
| Sight Sciences, Inc. | 166.65 Million USD | 95.384% |
| SI-BONE, Inc. | 230.42 Million USD | 96.662% |
| TELA Bio, Inc. | 78.04 Million USD | 90.145% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 96.946% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 28.313% |
| Acutus Medical, Inc. | 53.96 Million USD | 85.745% |
| Talis Biomedical Corporation | 98.34 Million USD | 92.178% |
| Spectral AI, Inc. | 10.69 Million USD | 28.058% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 96.482% |
| CVRx, Inc. | 115.22 Million USD | 93.325% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 86.887% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -146.914% |
| Bioventus Inc. | 810.91 Million USD | 99.051% |
| Venus Concept Inc. | 93.65 Million USD | 91.787% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 70.099% |
| LivaNova PLC | 2.42 Billion USD | 99.683% |
| 908 Devices Inc. | 202.98 Million USD | 96.21% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 99.045% |
| Nemaura Medical Inc. | 14.56 Million USD | 47.182% |
| NeuroPace, Inc. | 107.65 Million USD | 92.855% |
| LENSAR, Inc. | 69.58 Million USD | 88.946% |
| Apyx Medical Corporation | 79.24 Million USD | 90.293% |
| Cutera, Inc. | 346.29 Million USD | 97.779% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 81.693% |
| BioSig Technologies, Inc. | 1.79 Million USD | -327.809% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 97.158% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 81.969% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.797% |
| Axonics, Inc. | 719.92 Million USD | 98.932% |
| Outset Medical, Inc. | 313.8 Million USD | 97.549% |
| IRIDEX Corporation | 34.43 Million USD | 77.663% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 98.099% |
| IRadimed Corporation | 92.15 Million USD | 91.653% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -46.403% |
| INVO Bioscience, Inc. | 20.88 Million USD | 63.175% |
| Telesis Bio, Inc. | 70.41 Million USD | 89.076% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 95.009% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.384% |
| Quipt Home Medical Corp. | 247.4 Million USD | 96.891% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 17.379% |
| Pulmonx Corporation | 178.95 Million USD | 95.702% |
| Dynatronics Corporation | 25.94 Million USD | 70.348% |
| Modular Medical, Inc. | 13.8 Million USD | 44.289% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 28.293% |
| Semler Scientific, Inc. | 78.06 Million USD | 90.147% |
| InMode Ltd. | 863.28 Million USD | 99.109% |
| Bruker Corporation | 4.24 Billion USD | 99.819% |
| Cytosorbents Corporation | 53.26 Million USD | 85.558% |
| DexCom, Inc. | 6.26 Billion USD | 99.877% |
| Align Technology, Inc. | 6.08 Billion USD | 99.874% |
| Viveve Medical, Inc. | 25.91 Million USD | 70.316% |
| ZimVie Inc. | 1.2 Billion USD | 99.362% |
| Movano Inc. | 9.42 Million USD | 18.353% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 98.454% |
| Nexalin Technology, Inc. | 3.63 Million USD | -111.789% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 86.887% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.193% |
| Profound Medical Corp. | 43.68 Million USD | 82.393% |
| Insulet Corporation | 2.58 Billion USD | 99.703% |
| enVVeno Medical Corporation | 48.63 Million USD | 84.184% |
| Surmodics, Inc. | 185.73 Million USD | 95.859% |
| iCAD, Inc. | 41.41 Million USD | 81.428% |
| Nuwellis, Inc. | 9.77 Million USD | 21.269% |
| Biotricity, Inc. | 5.94 Million USD | -29.438% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 98.224% |
| Aethlon Medical, Inc. | 8.24 Million USD | 6.718% |
| InspireMD, Inc. | 47.64 Million USD | 83.855% |
| PAVmed Inc. | 33.11 Million USD | 76.775% |
| BIOLASE, Inc. | 35.1 Million USD | 78.086% |
| Beyond Air, Inc. | 56.96 Million USD | 86.496% |
| FONAR Corporation | 214.24 Million USD | 96.41% |
| AxoGen, Inc. | 196.82 Million USD | 96.092% |
| Vivani Medical, Inc. | 45.79 Million USD | 83.204% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 97.267% |
| Inari Medical, Inc. | 674.23 Million USD | 98.859% |
| UFP Technologies, Inc. | 404.13 Million USD | 98.097% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 67.126% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 19.058% |
| Tenon Medical, Inc. | 6.34 Million USD | -21.229% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 18.231% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 92.579% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.834% |
| Sintx Technologies, Inc. | 15.36 Million USD | 49.938% |
| NanoVibronix, Inc. | 6.67 Million USD | -15.253% |
| Quanterix Corporation | 425.01 Million USD | 98.19% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 17.379% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 85.683% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.559% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.911% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 87.828% |
| NeuroMetrix, Inc. | 21.42 Million USD | 64.097% |
| Hyperfine, Inc. | 94.19 Million USD | 91.834% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 97.137% |
| Biomerica, Inc. | 9.25 Million USD | 16.879% |
| Bone Biologics Corporation | 3.73 Million USD | -105.792% |
| AVITA Medical, Inc. | 144.33 Million USD | 94.671% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -57.994% |
| Silk Road Medical, Inc | 265.3 Million USD | 97.101% |